A series of angelicin heteroanalogues, in which the furan was replaced by t
hiophene or a 1-substituted pyrazole moiety, was synthesised in order to ob
tain potential therapeutic agents with antiproliferative and/or other biolo
gical activities. In general, the antiproliferative activity of the new thi
oangelicin, tested in different biological substrates, appeared to be highe
r than that of the angelicin, the natural parent compound, but lower than t
hat of 8-MOP, the furocoumarin ordinarily used in PUVA therapy and photophe
resis. Thioangelicin 6 induced strong inhibition of T2 bacteriophage infect
ivity and was able to significantly repress the DNA. synthesis in Ehrlich a
scites cells and the clonal growth in HeLa cells. The pyrazolocoumarins did
not show any noticeable effect upon UVA irradiation in all the biological
systems considered. All the new angelicin heteroanalogues appeared to be fr
ee of the known phototoxicity of furocoumarins on the skin. The pyrazolocou
marins have also been tested as anti-inflammatory, analgesic, antipyretic,
local anaesthetic, anti-arrhythmic and platelet antiaggregating agents by s
tandard procedures. In this class of derivatives, 10a showed good anti-infl
ammatory and antipyretic properties, while 9a and 11a showed significant lo
cal anaesthetic activity. (C) 1998 Elsevier Science S.A. All rights reserve
d.